4. LivaNova (Nasdaq:LIVN): +77.7%
Formed by the $2.7 billion merger of Italy’s Sorin and Cyberonics in October 2015, LivaNova (London) continues to expand its offerings in neuromodulation – which remains one of the hottest areas of growth in the medical device industry. The company in October announced FDA approvals for its latest vagus nerve stimulation therapy system – the SenTiva implantable generator and the next-generation VNS therapy programming system – for the treatment of people with drug-resistant epilepsy. Over the past week, LivaNova announced it would buy ImThera Medical and its implantable sleep apnea treatment for $225 million.During its third quarter, the company swung to profitability and upped its earnings outlook for the rest of 2017.
DMo says
Was going to read this article but refuse to go through multiple clicks to see a list. Can you just give the list?
Chris Newmarker says
There’s a link on the opening slide where you can download a full spreadsheet of 100 companies and their stock performance. Hope that helps.